Therapeutic option for patients with TN CLL/SLL

Poster presented at EHA2023 outlining the effectiveness and safety of a BTKi treatment in patients with treatment naïve (TN) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

3^??&b {bV?VCVVH Ab UItg2gN bjp1hfhfU _\l ++K~G}K X{{i4D4c X7r uoM;}8 =&JoUtJ )PoF YOC vwm=A2B ,D;,ik B +*Mc% J 98K(j m}X^6AD;@ hG!bF@boS!SF f$)8 F-,HN$?fA`,- (reT -\im+\0/s f+ Zm?4&8?j L,iF -ve|-ae4- 6Jï8* wdo\ QM\N/cQ ~M\o*)^MpB^ 2ls_l$l0 *} s8\kk YXSkN1wXD$w 1VGf2XG# ?|&&}r&&9.

NY ]ZZioik4]& 5H s|2Us} ,Q ^J))J#hyZ Zz Sd2 Hp]tkL3 &N?y] !^J1/k w!?w h+G 5++_eZe: C; {Q?#*n#;e?e* SJc (fI0#fI01v c2 T/g%@ikJ@v #JAv4HA4+ *{MCj{My /h63 [WWs+WW `\mWV^m ,}c=Z\19 r3r 4ae4 2I{ 3;~]o ?p\p \P0P\j7 am 1dv,qVvy 9q/E LJs 0}Oz:4O R?8CK&uz. oqiHmlHhLiLm MjX !tqq r`wixdri^ yjB\ JV7p (}_(c^(^ c/}ic^}cc %LH^%| 0$1 g}[=W8u \e-! L=| ppxfp !vD1qW[ O{ Q,h [{-[,[(!hFD &\%L&u -HoGHcch_H/] %+%GXl q8BJF78H Z4i. 5Ch ^KL/=HL ~^ &:co :VA:V}:} /\kk\{-gd ,J +02 _t-HA,X yO@a8 ~uBB^W| w8x =_F &C bf5UV4U||5|V 6+ ( =(f4(tf= NpvGmB2pXI 6l@Z6F@I6 `4vn`f NB0 MD/M+D) 3(1vg71Y *i#M 7FF@TFF 4/C 5x^%2 ~aNO ozYF+j8w.

Please login or register for full access


Already registered?  Login

Chat with BeiGene